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Abstract
Background: Radiographic contrast media exposition can cause acute renal function impairment. There is limited and 
conflicting evidence that hydration with sodium bicarbonate prevents contrast-induced nephropathy (CIN) in patients 
undergoing cardiac catheterization.
Objective: The present study was aimed at determining whether sodium bicarbonate is superior to hydration with 
saline to prevent nephropathy in patients at risk undergoing cardiac catheterization.
Methods: Three hundred and one patients undergoing coronary angiography or percutaneous coronary intervention 
with serum creatinine ≥ 1.2mg/dL or glomerular filtration rate (GFR) < 50ml/min were randomized to receive 
hydration with sodium bicarbonate starting 1 hour before the procedure and 6 hours after the procedure, or hydration 
with 0.9% saline. CIN was defined as an increase of 0.5mg/dL in creatinine in 48h
Results: Eighteen patients (5.9%) developed contrast induced nephropathy:  9 patients in the bicarbonate group 
(6.1%) and 9 patients in the saline group (6.0%), p = 0.97. The change in serum creatinine was similar in both 
groups, 0.01 ± 0.26 mg/dL in the bicarbonate group and 0.01 ± 0.35 mg/dL in the saline group, p = 0.9. No statistical 
difference was observed between the change in glomerular filtration rate (0.89 ± 9 ml/min vs. 2.29 ± 10 ml/min, p = 
0.2 bicarbonate group and saline group, respectively).
Conclusion: Hydration with sodium bicarbonate was not superior to saline to prevent contrast media induced 
nephropathy in patients at risk undergoing cardiac catheterization. (Arq Bras Cardiol 2012;99(6):1129-1134)
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Introduction
Contrast induced nephropathy (CIN) is a potential and 
important complication of the use of iodized radiological 
contrast agents. The development of CIN is associated 
with higher morbidity and mortality rates1-4 and increased 
length of hospitalization4 in patients undergoing cardiac 
catheterization.
One of the most used definition of CIN is an increase 
in serum creatinine greater than 0.5 mg/dL, occurring 
48 hours after exposure to contrast media1,5. In patients 
undergoing contrast-enhanced radiographic procedures, 
the incidence of CIN is approximately 3.5%1, ranging 
from 1% in previously healthy patients to more than 
50% in high-risk groups6-8. The main risk factors for CIN 
are previously impaired renal function1,9-11 and diabetes 
mellitus1. Moreover, other important risk factors are age1 
and the volume of contrast media administered during 
the procedure1,10.
Although effective preventive measures have been 
exhaustively sought12, only a few, such as hydration13 and 
the use of low-osmolality14 or isosmolar15 contrast agents, 
have proved useful.
In an initial study, hydration with sodium bicarbonate 
demonstrated to be superior to hydration with saline 
infusion for the prevention of CIN16. However, there is 
limited and controversial data regarding assessing the 
efficacy of sodium bicarbonate in patients undergoing 
cardiac catheterization17-23.
This is a multicenter, randomized clinical trial, which 
was carried out to evaluate the effect of hydration with 
sodium bicarbonate for prevention of CIN in patients at 
mild to moderate risk for developing CIN undergoing 
coronary angiography or  percutaneous coronary 
interventions (PCI).
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samples. Data were expressed as mean ± SD. For variables 
with nonparametric distribution, the Mann-Whitney test was 
used, data being expressed as median (25 percentile – 75 
percentile). Sample size was calculated as 298 individuals, to 
detect a 50% change in the relative risk for CIN associated 
with the hydration with sodium bicarbonate16,18, assuming a 
10% incidence of CIN in the group randomized to saline, with 
a power of 80% and α error of 0.05.
Odds ratio and 95% confidence intervals were calculated 
for the primary end-point outcomes for prespecified 
subgroups. Statistical analysis was carried out with the SPSS 
software, version 11.0 (SPSS Inc. Chicago, Illinois, USA).
Results
A total of 301 patients were randomized, 151 to receive 
saline infusion and 150 to sodium bicarbonate. The mean 
baseline serum creatinine and GFR of the study population 
were 1.50 ± 0.49mg/dL and 51.2 ± 13mL/min respectively. 
The baseline clinical characteristics and procedure related 
variables are shown in table 1. The mean age was 65.2 years. 
The groups were well balanced with respect to age, gender, 
blood pressure, diabetes mellitus, and drug therapy. 
The volume of contrast medium used during the 
procedures and the distribution of diagnostic angiography and 
PCI were similar in both groups. All patients completed the 
study protocol. No adverse reaction to hydration was reported.
Primary Outcomes
Hydration with sodium bicarbonate was not superior to 
saline for prevention of CIN. The incidence of CIN was similar 
in the 2 groups, occurring in 9 patients (6.1%) in the sodium 
bicarbonate group and in 9 patients (6.0%) in the saline group 
(p = 1.0) (table 2).
The changes in serum creatinine from baseline to 
48h after contrast exposition in the sodium bicarbonate 
and saline groups were also similar (0.01 ± 0.26 mg/dL 
vs. 0.01 ± 0.35 mg/dL, p = 0.9 respectively) (Table 2).
No significant difference was found when the changes in 
GFR were compared between the groups (0.9 ± 8.0 ml/min 
in the sodium bicarbonate group and 2.3 ± 10 ml/min in the 
saline group, p = 0.2) (Table 2).
Secondary Outcomes
No difference in secondary outcomes was observed 
between the groups (Table 2). The length of hospitalization, 
need for hemodialysis, and in-hospital death were similar in 
both groups. A total of 13 (4.3%) patients died in hospital, six 
in the sodium bicarbonate group and seven in the saline group. 
In the sodium bicarbonate group, 2 patients died following PCI 
complications, 2 patients died by postoperative complications 
of coronary artery bypass graft (CABG) surgery and 2 patients 
died of no cardiac causes. Only 1 of these deaths occurred 
in patients who developed CIN.
Of the 7 deaths that had occurred in the saline infusion 
patients, four were related to postoperative complications in 
patients who underwent CABG, two died of cardiac causes 
Methods
Patients
The study randomized 301 patients at moderate to high risk 
for developing CIN who were referred for elective coronary 
angiography or PCI at 6 centers.
Patients were eligible for the study if they had one of the 
following criteria: serum creatinine ≥ 1.2 mg/dL or glomerular 
filtration rate (GFR) < 50 mL/min. The GFR was calculated 
using the Modification of Diet in Renal Disease group 
equation (MDRD)24. The exclusion criteria were as follows: 
age < 18 years, use of radiographic contrast media during the 
last 21 days, history of dialysis, cardiac insufficiency class III-IV 
NYHA, and emergency procedures. The ethics committees of 
the 9 hospitals approved the study protocol. Written informed 
consent was obtained from all patients included in the study.
Protocol of the Study
The patients were randomized to receive hydration with 
sodium bicarbonate, or 0,9% saline by randomly drawing sealed 
envelopes. Randomization was stratified manner by the type of 
the procedure to be performed (coronary angiography or PCI). 
The patients randomized for the sodium bicarbonate group 
received 154 mEq/l of sodium bicarbonate in 5% dextrose 
and H2O, and patients randomized for saline solution received 
hydration with 0.9% saline infusion, according to the protocol 
reported by Merten et al16. The initial intravenous bolus was 
3 mL/ kg/ h for 1 hour immediately before contrast injection. 
After that, patients received the same fluid at a rate of 1 mL/kg/h 
during contrast exposure and for 6 hours after the procedure. 
The 2 fluids were administered in an open-label basis.
All the procedures were performed with low-osmolality 
ionic contrast medium (Hexabrix, Ioxaglate; Guerbet Ltda, 
Rio de Janeiro, Brazil).
Outcomes
Serum creatinine was measured 24 hours before 
(baseline creatinine) and 48 hours after the procedure 
(post-procedure creatinine).
The primary outcomes were predefined as follow: 1) the 
occurrence of CIN, defined as an increase in serum creatinine 
≥ 0.5 mg/dL 48 hours after exposure to contrast medium; 2) the 
variation in serum creatinine (post-procedure Cr – baseline Cr); 
and 3) the variation in GFR (post-procedure GFR – baseline GFR). 
Secondary outcomes were need for dialysis during 
hospitalization, length of hospitalization, and in-hospital mortality.
The effect of sodium bicarbonate was also assessed in the 
following predefined subgroups: baseline GFR ≤ 40 ml/min, 
diabetes mellitus, age > 70 years, and patients receiving a 
contrast media volume ≥ 1.5 ml/Kg.
Analysis Statistics
Analysis was conducted on an intention to treat basis. 
The categorical variables were analyzed with the chi-square 
test or Fisher exact test as appropriate, and the continuous 
variables were analyzed with the Student t test for independent 
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Table 1 - Baseline clinical characteristics and procedure related variables
Saline
n =151
Bicarbonate
n = 150 p
Age, years (SD) 64,5 (± 12) 64,1 (± 12) 0,74
Male gender (%) 74,8 69,3 0,28
Black race (%) 16,0 14,9 0,78
Creatinine, mg/dL (SD) 1,49 (± 0,5) 1,50 (± 0,4) 0,85
Creatinine ≥ 2.5 mg/dL, n (%) 4 (2,6%) 7 (4,7%) 0,35
† GFR, mL/min (SD) 51,9 (± 13) 50,5 (± 13) 0,36
Blood Pressure (mm/Hg)
          Systolic 129,3 (± 21) 130,0 (± 20) 0,73
          Diastolic 75,9 (± 12) 78,1 (± 12) 0,10
History of hypertension (%) 74,2 77,3 0,52
Diabetes mellitus (%) 29,8 28,7 0,83
Insulin (%) 11,3 12,0 0,84
Medical therapy
Diuretics (%) 29,1 34,0 0,36
Ca++ channel blocker (%) 12,6 13,3 0,84
*ACE Inhibitor (%) 63,6 64,0 0,94
Angiographic findings (%) 0,81
Non-obstructive disease 26,5 25,0
1 vessel disease 29,1 30,4
2 vessel disease 19,2 18,2
3 vessel disease 25,2 26,4
‡ LV ejection fraction, % (SD) 56 ± 21 52 ± 17 0,35
Procedure type 0 44
          Coronary angiography (%) 84,8
          § PCI (%) 15,2 18,7
          Contrast Volume (mL) 125 (± 87) 124 (± 65) 0,86
*ACE: angiotensin-converting enzyme; †GFR: Glomerular filtration rate; *ACE: angiotensin-converting enzyme; §PCI: Percutaneous coronary intervention; 
‡LV: left ventricular.
Table 2 - Primary and secondary outcomes in the saline and sodium bicarbonate group
Saline
(n =151)
Bicarbonate
(n = 150) p
Primary Outcomes
          Incidence of CIN* (%)          6.0             6.1 0.97
          Change in Cr†, mg/dl          0.01  ± 0.3             0.01± 0.2 0.92
          Change in GFR‡, ml/min          2.29 ± 10             0.89 ± 9 0.20
Secondary Outcomes
          Length of hospitalization, days          8.6 ± 9.7             7.5 ± 10 0.35
          Dialysis (%)          0             0 1.00
          Death (%)          3.4             4.7 0.81
*CIN: Contrast induced nephropathy; †Cr: serum creatinine; ‡GFR: glomerular filtration rate.
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and 1 patient died due to no cardiac cause. None of the 
patients of this group who died developed CIN. 
Sub-Groups Analysis
The lack of efficacy of sodium bicarbonate compared 
to normal saline was consistent among the prespecified 
subgroups including both low and high-risk patients (Table 3).
Discussion
The main finding of this multicenter clinical trial is that, in 
patients with mild renal dysfunction, hydration with sodium 
bicarbonate is not superior to saline infusion to reduce the 
incidence of CIN after cardiac catheterization. Moreover, 
hydration with sodium bicarbonate demonstrated no benefit 
in any of the predefined subgroups.  
The pathophysiology of CIN is poorly understood. It 
certainly involves the interplay of multiples factors; however, 
little is known about the underlying cellular mechanisms25. 
Evidence suggests that free radicals have important role in 
the development of CIN associated with direct injury to the 
tubular epithelium26-28. Once the acidic environment typical 
of renal tubules propitiates the formation of free radicals is 
possible that alkalinization of urine may reduce the incidence 
of CIN. In animal models of ischemic acute renal insufficiency, 
sodium bicarbonate is more protective than saline solution29. 
Merten and cols16 were the first to report an important 
reduction in the risk of CIN in patients hydrated with 
sodium bicarbonate (1.7% versus 13.6% p= 0.02, sodium 
bicarbonate and saline solution, respectively). However, that 
was a single-center study that involved only 119 patients 
who underwent many types of procedures with radiological 
contrast and not only cardiac catheterization. Moreover, they 
used more than one type of contrast and the administration 
route of the contrast agent was not only intra-arterial.
Posterior studies evaluated sodium bicarbonate in the 
prevention of CIN in patients submitted to the angiography 
and/or PCI produced conflicting results17-23. Some of these 
studies evaluated the use of sodium bicarbonate plus 
N-acetylcysteine17,19,21,23 and, therefore, do not allow for a 
definitive conclusion regarding the benefit of isolated sodium 
bicarbonate in CIN prophylaxis, once the evaluation of two 
drugs simultaneously is an important confusion bias. Among 
studies that compared only sodium bicarbonate and saline 
solution, the results are also inconsistent18,20,22. The present 
study is the only multicenter and has the largest sample size 
among the studies that evaluated hydration with bicarbonate 
as a single approach for CIN prophylaxis.
There are important differences among studies assessing 
sodium bicarbonate for CIN prophylaxis. First, different 
definitions of CIN have been used. Previous studies define CIN 
either as an absolute rise in serum creatinine of 0,5 mg/dl, or an 
increase of 25% in relation to baseline. In this study, we elect 
to use an absolute increase in serum creatinine of 0.5mg/dl 
as primary end point because we consider this definition has 
superior clinical relevance. This definition determines that the 
diagnosis of CIN is restricted to a smaller number of patients. It 
is conceivable that diverse results were obtained if a different 
CIN definition was used30,31.
 Variation in hydration protocols may account for different 
results. We use the same hydration protocol and bicarbonate 
administration carried out by the initial study of Merten 
and cols16. Only one additional study evaluated the same 
bicarbonate protocol and showed superiority of bicarbonate. 
However, that was a single-center study and that included 
only 59 patients20.
Another potential source of variability is the type of contrast 
used by studies evaluating CIN prophylaxis. In our study, 
all patients received ionic low osmolality contrast media. 
Previous studies had tested sodium bicarbonate in patients 
that received ionic and nonionic contrast agents with different 
osmolality. This may also contribute to the inconsistent results 
seen in literature, as different contrast agents have different 
risk of CIN32. 
Two meta-analyses recently published indicate superiority 
of the hydration with sodium bicarbonate in the prevention of 
the CIN. In both of them, the authors demonstrated significant 
heterogeneity between studies and evidence of publication 
bias favoring sodium bicarbonate therapy33,34. Moreover, the 
findings were importantly influenced by the dramatic effect 
of the treatment demonstrated in small studies. Therefore, 
Table 3 - Incidence of CIN and risk ratios in sub-group analysis
n SF 0.9% Bicarbonate OR IC p
DM 87 8.9 9.8 1.08 0.25 – 4.62 0.97
Non DM 214 4.7 4.7 1.00 0.28 – 3.56 1.00
GFR ≤ 40 ml/min 60 22.2 18.2 0.7 0.21 – 2.76 0.75
GFR > 40 ml/min 241 2.4 2.6 1.08 0.21 – 5.46 1.00
Age > 70 98 5.5 11.6 2.28 0.51 – 10.1 0.30
Age ≤ 70 203 6.3 3.8 0.6 0.16 – 2.17 0.42
Contrast Vol ≥ 1.5 ml/Kg 132 10.7 4.4 0.38 0.09 – 1.52 0.24
Contrast Vol < 1.5 ml/Kg 169 2.7 7.6 3.00 0.56 – 15.9 0.25
DM: Diabetes mellitus; GFR: Glomerular filtration rate
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the results of these meta-analyses must be interpreted with 
caution because of those limitations.  
Our study found no benefit of hydration with sodium 
bicarbonate in patients with mild to moderate renal dysfunction. 
However, this does not allow us to draw definite conclusion 
about the effect of sodium bicarbonate on very high-risk 
patients, once only 3.6% of the patients had serum creatinine 
≥ 2.5 mg/dl. Nevertheless, considering that only 4% of the 
population who undergo cardiac catheterization present serum 
creatinine > 2,0 mg/dl 1, the present findings can be applied to 
the majority of the patients at risk for developing CIN.
The incidence of CIN observed in our study was lower 
in both groups compared to that of previous studies with a 
similar patient population23,35. There are a number of possible 
explanations for this difference. Our study was specifically 
designed to compare two hydration protocols that were 
rigorously executed in the control and bicarbonate groups. It 
is conceivable to assume that adequate hydration determined 
the low incidence of NIC regardless of sodium bicarbonate use.
Once the rise of creatinine is a surrogate end-point, we 
also evaluate the effect of hydration with sodium bicarbonate 
in hard outcomes (in-hospital mortality, necessity of dialysis 
and length of hospitalization). Our study did not show any 
advantage of sodium bicarbonate over saline infusion. Higher 
than expected in-hospital mortality observed in this study can 
be explained by the high cardiovascular risk of patients, since 
that most deaths were due to complications of CABG.
Limitations of the Study
This study has some potential limitations. Serum 
creatinine was measured 48h after the procedure; although 
most clinical trials on preventive measures for CIN have 
assessed creatinine during that period, it is possible that 
a later increase in serum creatinine may have passed 
unnoticed in some patients. Urinary pH was not measured 
after the procedure to determine the effectiveness of sodium 
bicarbonate. Only ionic low osmolality contrast media was 
used; therefore, the findings of this study may not be applied 
to patients who receive another type of contrast. Finally, 
sample size was calculated aiming at reaching statistical 
difference in primary outcomes. Therefore, although no 
trends were observed in subgroups, our study has limited 
statistical power for that analysis.
Conclusion
The results of this multicenter study indicated that hydration 
with sodium bicarbonate is not superior to hydration with 
saline infusion in patients with mild to moderate renal 
dysfunction who were undergoing coronary angiography.
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